Clinical trial
The Efficacy of Hydroxychloroquine on Behcet's Disease Thrombotic Events Prevention
NCT04022421 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Hydroxychloroquine on Behcet's Disease Thrombotic Events Prevention
- Lead sponsor
- Assiut University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 1, 2018
- Completion date
- October 31, 2019
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
behcet's syndrome, vascular type